Ionis Pharmaceuticals | IONS - 营业利润



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.79B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


营业利润 更改 日
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Arrowhead Research USD -170.09M 28.83M 2026-06
Astellas Pharma JPY 185.36B 136.79B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Exelixis USD 248.41M 2.93M 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.75B 515M 2026-06
Omeros USD -35.41M 23.75M 2024-09
OPKO Health USD -51.02M 12.7M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD 667M 4.32B 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Qiagen NV USD 141.4M 24.77M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 362.83M 474.98M 2026-06